Q1 2024 · 13F-HR
CARNEGIE MELLON UNIVERSITYholdings as filed
Filed 2024-05-07 · accession 0000898432-24-000377
$80.1M
Reported value
6
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 26603R106 | DUOL | DUOLINGO INC | $79.0M | 98.7% | 358,314 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $692,507 | 0.87% | 16,060 | Common | SOLE |
| 142922103 | — | CARMELL CORPORATION | $263,836 | 0.33% | 103,061 | Common | SOLE |
| 74039M309 | POAIEUR | PREDICTIVE ONCOLOGY INC | $26,413 | 0.03% | 10,358 | Common | SOLE |
| 64132K201 | OHRPEUR | NEUBASE THERAPEUTICS INC | $21,132 | 0.03% | 46,970 | Common | SOLE |
| 457919108 | IHT | INNSUITES HOSPITALITY TRUST | $13,200 | 0.02% | 10,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.